Search Results
JEL Code: L65

136,747 Total downloads

Viewing: 651 - 671 of 671 papers

651.

Radioactive Warfare: Depleted Uranium Weapons, the Environment, and International Law

Environmental Law Reporter, Vol. 36, p. 10474
Posted: 23 May 2006
Accepted Paper Series
Florida A&M University College of Law
652.

Regulatory Threats and Political Vulnerability

Journal of Financial Research
Posted: 11 Apr 2000
Accepted Paper Series
University of Auckland - Department of Accounting and Finance, Monash University and University of Tulsa
653.

Research Collaboration and Publication's Citation Impact: Evidence in the Italian Biotech Sector

Rivista Italiana degli Economisti, Vol. 1, April 2012
Posted: 12 Mar 2012
Accepted Paper Series
affiliation not provided to SSRN, University of Ferrara - Faculty of Economics and affiliation not provided to SSRN
654.

Sham Litigation in the Pharmaceutical Sector

European Competition Journal, Vol. 7, No. 3, pp. 455-503, December 2011
Posted: 31 Jan 2012
Accepted Paper Series
Princeton University - Princeton School of Public and International Affairs
655.

Site Hazard, Settlement Activity, and Superfund Liability Valuation

Posted: 17 Jun 1996
Working Paper Series
University of Maryland, University of Melbourne and University of Washington - Department of Accounting
656.

Taking Stock of the Genetically Modified Seed Sector Worldwide: Market, Stakeholders, and Prices.

Food Security 4(6), August 2014, pp. 525-540. DOI:10.1007/s12571-014-0357-1
Posted: 22 Aug 2014
Accepted Paper Series
INRA, UMR Economie Publique, F-78850 GRIGNON, FRANCE
657.

Technological Breadth and Depth of Knowledge in Innovation: The Role of Mergers and Acquisitions in Biotech

Industrial and Corporate Change, 2014
Posted: 25 Apr 2015
Accepted Paper Series
Middlesex University and Independent
658.

Technological Capabilities and Firm Resources as Determinants of Export Competitiveness - Evidence from Indian Pharmaceutical Industry Using Quantile Regression Approach

Rentala, S., Anand, B., & Shaban, M. (2014). Technological capabilities and firm resources as determinants of export competitiveness - Evidence from Indian pharmaceutical industry using quantiler egression approach. Journal of Medical Marketing, 14(2-3), 133-144
Posted: 04 Jan 2016
Accepted Paper Series
Pondicherry University - Department of Management (Karaikal Campus), Bharathidasan Institute of Management and Independent
659.

The Battle for Patent Rights in Plant Biotechnology: Evidence from Opposition Filings

Journal of Technology Transfer, Forthcoming
Posted: 21 Feb 2011
Accepted Paper Series
Copenhagen Business School - Department of Economics
660.

The Bio-Incubation Boom in India

Posted: 29 Sep 2019
Working Paper Series
Biotechnology Industry Research Assistance Council and Institute of Bioinformatics and Applied Biotechnology
661.

The Complementary Relationship Between Financial and Non-Financial Information in the Biotechnology Industry and the Degree of Investor Sophistication

Journal of Contemporary Accounting and Economics, Forthcoming
Posted: 06 Aug 2010
Accepted Paper Series
University of Toronto - Rotman School of Management, Ben-Gurion University of the Negev and Interdisciplinary Center (IDC) Herzliyah
662.

The Effects of Pharmaceutical Marketing and Promotion on Adverse Drug Events and Regulation

American Economic Journal: Economic Policy 2 (November 2010): 1-25
Posted: 15 Mar 2015
Accepted Paper Series
Carnegie Mellon University - H. John Heinz III School of Public Policy and Management, The Wharton School, University of Pennsylvania - Health Care Management and Emory University

Multiple version iconThere are 2 versions of this paper

663.

The Impact of Direct-to-Consumer Advertising of Cholesterol Reducing Drugs on Diagnosis and Treatment of Cholesterol

iHEA 2007 6th World Congress: Explorations in Health Economics Paper
Posted: 17 Jun 2007
Working Paper Series
Cornell University, Cornell University - Department of Policy Analysis & Management (PAM), Cornell University - Department of Policy Analysis and Management, Cornell University - Department of Policy Analysis & Management (PAM) and Cornell University - Department of Policy Analysis & Management (PAM)
664.

The Risk We Bear: The Effects of Review Speed and Industry User Fees on New Drug Safety

Journal of Health Economics, Vol. 27, No. 2, 2008
Posted: 21 Mar 2008
Accepted Paper Series
Tulane University
665.

The Role of Diversification Profiles and Dyadic Characteristics in the Formation of Technological Alliances: Differences between Exploitation and Exploration in a Low-Tech Industry

Research Policy 45: 517-532, 2016
Posted: 07 Jun 2015 Last Revised: 08 Jul 2017
Accepted Paper Series
University of Exeter Business School
666.

The Strategic Response by Pharmaceutical Firms to the Medicaid Most-Favored-Customer Rules

RAND JOURNAL OF ECONOMICS, Vol. 28, No. 2, 1997
Posted: 25 Jun 1997
Accepted Paper Series
Yale School of Management

Multiple version iconThere are 2 versions of this paper

667.

The US Patent Holdings of Homegrown Indian Biotech and Pharma Companies

Current Science, 96, 252-259, 2009
Posted: 31 Jan 2016 Last Revised: 27 Feb 2016
Accepted Paper Series
Institute of Bioinformatics and Applied Biotechnology, Institute of Bioinformatics and Applied Biotechnology, Independent and Institute of Bioinformatics and Applied Biotechnology
668.

Trouble in Mesopotamia: Can America Deter a Water War between Iraq, Syria, and Turkey?

Environmental Law Reporter, Vol. 34, No. 10362, 2004
Posted: 13 Dec 2007
Accepted Paper Series
Environmental Consultant
669.

Voluntary Disclosure in R&D Intensive Industries

Contemporary Accounting Research, Vol. 24, No. 2, Summer 2007
Posted: 11 Feb 2007
Accepted Paper Series
College of William and Mary - Mason School of Business
670.

What Prices Can Tell Us About the Market for Antibiotics

Posted: 15 Sep 1998
Working Paper Series
Massachusetts Institute of Technology (MIT) - Department of Economics
671.

Work Outsourced to Indian Biotech and Pharma Companies is Not Yet Significantly Innovative

Current Science, 102, 401-404, 2012
Posted: 01 Feb 2016 Last Revised: 27 Feb 2016
Accepted Paper Series
Institute of Bioinformatics and Applied Biotechnology, Institute of Bioinformatics and Applied Biotechnology and Institute of Bioinformatics and Applied Biotechnology